Complications Associated with Intraperitoneal Chemotherapy Catheters

This publication has 15 references indexed in Scilit:

• Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  JNCI Journal of the National Cancer Institute, 2000
• Phase II Trial of Intraperitoneal Cisplatin and Mitoxantrone in Patients with Persistent Ovarian Cancer
  Gynecologic Oncology, 1999
• Cancer statistics, 1999
  CA: A Cancer Journal for Clinicians, 1999
• A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment
  Gynecologic Oncology, 1998
• Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
  Gynecologic Oncology, 1998
• Pharmacokinetic Problems in Peritoneal Drug Administration: Tissue Penetration and Surface Exposure
  JNCI Journal of the National Cancer Institute, 1997
• Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
  New England Journal of Medicine, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Intraperitoneal chemotherapy: Analysis of complications with an implanted subcutaneous port and catheter system
  Gynecologic Oncology, 1991
• Pharmacology of Intraperitoneal Chemotherapy
  Cancer Investigation, 1983